Literature DB >> 9334865

Immunogenicity and reactogenicity of HbOC vaccine administered simultaneously with acellular pertussis vaccine (DTaP) into either arms or thighs of infants.

H J Schmitt1, C H Wirsing von König, F Zepp, J Huff, K Jahn, P Schmidtke, C Meyer, P Habermehl, R Uhlenbusch, P Angersbach.   

Abstract

To evaluate the reactogenicity and immunogenicity of a Haemophilus influenzae type b conjugate vaccine (HbOC) and of a tricomponent acellular pertussis vaccine (DTaP) when injected simultaneously into either contralateral arms or into contralateral thighs, 110 infants were enrolled to receive three doses of DTaP at 3, 4, and 5 months and two HbOC doses at 3 and 5 months of age. Administration of either of the two vaccines into arms was associated with significantly more local side effects than administration into thighs. There was no difference in geometric mean concentration (GMC) values for any of the four vaccine antigens between subjects who had been vaccinated into arms or thighs. After immunization, all children had protective antibody titers to diphtheria toxin. While post vaccination the mean anti-tetanus toxoid GMC was > or = 1.25 IU/ml, there was no significant rise as compared to the GMC before vaccination. GMCs of antibodies against the various pertussis antigens were similar to those observed before with the same DTaP vaccine. The simultaneous administration of DTaP and HbOC was safe and immunogenic irrespective of the site of vaccine administration, but significantly more local reactions occurred when vaccines were injected into arms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9334865     DOI: 10.1007/bf01720400

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  19 in total

1.  Pertussis antibodies, protection, and vaccine efficacy after household exposure.

Authors:  J Storsaeter; W C Blackwelder; H O Hallander
Journal:  Am J Dis Child       Date:  1992-02

2.  Suboptimal response to hepatitis B vaccine given by injection into the buttock.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1985-03-01       Impact factor: 17.586

3.  Comparison of 13 acellular pertussis vaccines: overview and serologic response.

Authors:  K M Edwards; B D Meade; M D Decker; G F Reed; M B Rennels; M C Steinhoff; E L Anderson; J A Englund; M E Pichichero; M A Deloria
Journal:  Pediatrics       Date:  1995-09       Impact factor: 7.124

4.  Comparison of 13 acellular pertussis vaccines: adverse reactions.

Authors:  M D Decker; K M Edwards; M C Steinhoff; M B Rennels; M E Pichichero; J A Englund; E L Anderson; M A Deloria; G F Reed
Journal:  Pediatrics       Date:  1995-09       Impact factor: 7.124

5.  Immunoenzymatic assay of anti-diphtheric toxin antibodies in human serum.

Authors:  M E Camargo; L Silveira; J A Furuta; E P Oliveira; O A Germek
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

6.  A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera.

Authors:  M E Melville-Smith; V A Seagroatt; J T Watkins
Journal:  J Biol Stand       Date:  1983-04

7.  Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.

Authors:  S B Black; H R Shinefield; B Fireman; R Hiatt; M Polen; E Vittinghoff
Journal:  Pediatr Infect Dis J       Date:  1991-02       Impact factor: 2.129

8.  Measurement of anti-Haemophilus influenzae type b capsular polysaccharide antibodies by ELISA.

Authors:  A Barra; D Schulz; P Aucouturier; J L Preud'homme
Journal:  J Immunol Methods       Date:  1988-11-25       Impact factor: 2.303

9.  Recommendations for use of Haemophilus b conjugate vaccines and a combined diphtheria, tetanus, pertussis, and Haemophilus b vaccine. Recommendations of the advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1993-09-17

10.  A placebo-controlled trial of a pertussis-toxoid vaccine.

Authors:  B Trollfors; J Taranger; T Lagergård; L Lind; V Sundh; G Zackrisson; C U Lowe; W Blackwelder; J B Robbins
Journal:  N Engl J Med       Date:  1995-10-19       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.